Physician profile
Bruce Klaskin
NPI 1578556536
$1,665.26
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $335 · 2021: $576 · 2022: $401.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $230.64 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $204.93 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $181.72 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $169.83 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $141.92 | 2020-2021 | |
| Lilly USA, LLC | $115.92 | 2019-2022 | |
| Allergan, INC. | $92.88 | 2020 | |
| Abbvie INC. | $91.38 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $75.92 | 2022 | |
| Pfizer INC. | $70.94 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.58 | 2019-2022 | |
| Amgen INC. | $54.39 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $45.03 | 2019 | |
| Scilex Pharmaceuticals INC. | $44.18 | 2019 | |
| Electronic Waveform Lab, INC. | $26.20 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $21.67 | 2019 | |
| Eisai INC. | $14.20 | 2020 | |
| Medtronic USA, INC. | $10.82 | 2019 | |
| Forte Bio-Pharma LLC | $9.11 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Klaskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.